Related Experiment Video
Updated: Apr 16, 2026
05:10
Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
1.5K
Physician knowledge about and perceptions of obesity management
Terry Ann Glauser1, Nancy Roepke1, Boris Stevenin2
1CE Outcomes, LLC, 107 Frankfurt Circle, Birmingham, AL 35211, United States.
Obesity Research & Clinical Practice
|March 21, 2015
Summary
Physician knowledge gaps regarding obesity pathophysiology and treatment efficacy persist. Many primary care physicians, endocrinologists, and cardiologists lack understanding of obesity medication and surgical outcomes.
Area of Science:
- Medical Science
- Public Health
Background:
- Obesity affects approximately 35% of US adults, representing a significant public health challenge.
- Understanding physician knowledge and practice patterns is crucial for improving obesity management.
Purpose of the Study:
- To assess the knowledge and practice patterns of primary care physicians (PCPs), endocrinologists (ENDOs), cardiologists (CARDs), and bariatricians (BARIs) concerning obesity management.
Main Methods:
- A case vignette survey was emailed and faxed to 1625 US-based physicians in February 2013.
- Results were analyzed using PASW Statistics 18.
Main Results:
- Respondents (100 PCPs, 100 ENDOs, 70 CARDs, 30 BARIs) generally viewed obesity as a disease but attributed it to lack of self-control.
- Familiarity with obesity guidelines was low, with no consensus on initiating weight-loss medication.
- Physicians often overestimated pharmacotherapy weight loss and underestimated surgical weight loss, except for bariatricians.
Conclusions:
- Physicians demonstrated knowledge gaps in obesity guidelines and pathophysiology.
- There was a general lack of understanding regarding the efficacy, safety, and mechanism of action of obesity medications.
Related Concept Videos
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
413
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
413
01:21Drug Dosing: Obese Patients
349
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
349
01:20Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
307
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
307
01:24Obesity
1.6K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.6K
01:15Diabetes: Management and Pharmacotherapy
1.5K
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.5K
01:29Assessment of the Gastrointestinal System II: Health Perception Pattern
607
Assessing the gastrointestinal (GI) system is a complex process that begins with collecting subjective data. This data, collected through patient interviews, provides crucial insights into the patient's health history, perception patterns, and lifestyle habits, all contributing significantly to GI health.
Health Perception Patterns
Health perception patterns offer valuable insights into a patient's lifestyle habits and how they may impact their GI health. These patterns include:
Health Perception Patterns
Health perception patterns offer valuable insights into a patient's lifestyle habits and how they may impact their GI health. These patterns include:
607